[Significances of RET fusion gene in non-small cell lung cancer]
1Department of Medical Oncology, the First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
Abstract:
Lung cancer is the leading cause of cancer-related death worldwide, molecular target therapy has become a hot research direction of non-small cell lung cancer (NSCLC) treatment. RET fusion gene with an identifiable clinical pathological features, is present in some subsets of lung cancer, and its treatment is effective by RET inhibitor, suggesting that RET fusion gene may be a new target for individualized treatment to the subgroup of NSCLC. This article reviews the structural characteristics of RET fusion gene and expression model in clinical samples, and treatment of NSCLC.
Insights
RET fusion genes are key targets in non-small cell lung cancer (NSCLC) treatment. Targeting these RET fusions with specific inhibitors offers a promising approach for personalized NSCLC therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Lung cancer remains a leading cause of cancer mortality globally.
- Molecular targeted therapy is a significant area of research for non-small cell lung cancer (NSCLC).
- RET fusion genes present distinct clinical and pathological features in specific lung cancer subsets.
Purpose:
- To review the structural characteristics of RET fusion genes.
- To examine the expression models of RET fusion genes in clinical samples.
- To discuss the therapeutic implications of targeting RET fusions in NSCLC.
Summary:
- RET fusion genes are identified in subsets of NSCLC patients.
- Effective treatment is achievable using RET inhibitors for tumors with these fusions.
- This suggests RET fusion genes are a viable target for individualized NSCLC treatment strategies.
Impact:
- Highlights RET fusion genes as a potential biomarker for personalized NSCLC therapy.
- Emphasizes the efficacy of RET inhibitors in a specific NSCLC subgroup.
- Provides insights into the structural and expression patterns of RET fusions relevant to clinical application.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation


